BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND PPFIBP1, L2, 8496, ENSG00000110841, hSGT2, hSgt2p
209 results:

  • 1. Long-term prediction by DNA methylation of high-grade cervical intraepithelial neoplasia: Results of the ARTISTIC cohort.
    Gilham C; Nedjai B; Scibior-Bentkowska D; Reuter C; Banwait R; Brentnall AR; Cuzick J; Peto J; Lorincz AT
    Int J Cancer; 2024 Jul; 155(1):81-92. PubMed ID: 38507581
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Mismatch repair gene
    Zhou LZ; Xiao HQ; Chen J
    Front Immunol; 2024; 15():1302797. PubMed ID: 38390329
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Whole-genome analysis and evolutionary characterization of cervical and oral human papillomavirus 16.
    Minhas S; Kashif M; Nisar H; Idrees M; Ansari F
    Exp Biol Med (Maywood); 2023 Dec; 248(23):2332-2340. PubMed ID: 38196081
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Linking tumor immune infiltrate and systemic immune mediators to treatment response and prognosis in advanced cervical cancer.
    Rocha Martins P; Luciano Pereira Morais K; de Lima Galdino NA; Jacauna A; Paula SOC; Magalhães WCS; Zuccherato LW; Campos LS; Salles PGO; Gollob KJ
    Sci Rep; 2023 Dec; 13(1):22634. PubMed ID: 38114557
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Accuracy of 3-D Surface Rendering of 2-D Ultrasound Images of the Uterus Using a Novel Software in Mapping uterine Fibroids.
    Guruvare S; Hebbar S; Bai L; Jaiprakash P; Reddy D; Hc D
    Ultrasound Med Biol; 2024 Jan; 50(1):128-133. PubMed ID: 37821244
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Advances in molecular mechanism of HPV16 E5 oncoprotein carcinogenesis.
    Chen B; Zhao L; Yang R; Xu T
    Arch Biochem Biophys; 2023 Sep; 745():109716. PubMed ID: 37553047
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A novel human papillomavirus and host DNA methylation score and detection of cervical adenocarcinoma.
    Gradissimo A; Clarke MA; Xue X; Castle PE; Raine-Bennett TR; Schiffman M; Wentzensen N; Strickler HD; Burk RD
    J Natl Cancer Inst; 2023 Dec; 115(12):1535-1543. PubMed ID: 37467068
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Tumor-TME Bipartite Landscape of PD-1/PD-L1 in Endometrial cancers.
    Sulaiman R; De P; Aske JC; Lin X; Dale A; Koirala N; Gaster K; Espaillat LR; Starks D; Dey N
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446260
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The effect of Wnt/β-catenin signaling on PD-1/PDL-1 axis in HPV-related cervical cancer.
    Aghbash PS; Hemmat N; Baradaran B; Mokhtarzadeh A; Poortahmasebi V; Oskuee MA; Baghi HB
    Oncol Res; 2022; 30(3):99-116. PubMed ID: 37305016
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The expression of programmed death-ligand 1 and programmed death-ligand 2 in endometrial carcinosarcoma: Correlation with mismatch repair protein expression status, tumor-infiltrating lymphocyte infiltration, and clinical outcomes.
    Atılgan AO; Tepeoğlu M; Özen Ö; Reyhan ANH; Ayhan A
    Ann Diagn Pathol; 2023 Aug; 65():152137. PubMed ID: 37060883
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Severe hematuria in a patient receiving bevacizumab and pembrolizumab for metastatic cervical cancer: a case report.
    Liu Y; Dong C; He X; Wu P; Shu Y; Chen L
    BMC Nephrol; 2023 Mar; 24(1):51. PubMed ID: 36899322
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Lymphocyte activation gene (LAG)-3 is a potential immunotherapeutic target for microsatellite stable, programmed death-ligand 1 (PD-L1)-positive endometrioid endometrial cancer.
    Hong JH; Cho HW; Ouh YT; Lee JK; Chun Y
    J Gynecol Oncol; 2023 Mar; 34(2):e18. PubMed ID: 36509464
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Convolutional Neural Networks for Classifying Cervical cancer Types Using Histological Images.
    Li YX; Chen F; Shi JJ; Huang YL; Wang M
    J Digit Imaging; 2023 Apr; 36(2):441-449. PubMed ID: 36474087
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Detection of HPV16 viral load in L2 gene as a related predictor of cervical cancer among women in Dhi-Qar province by qRT-PCR.
    Jalil AT; Khan MUF; Muhammed HA; Kawen AA; Saeed BQ; Karevskiy A
    Mol Biol Rep; 2022 Dec; 49(12):11847-11853. PubMed ID: 36214947
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Novel Vaccine Strategies and Factors to Consider in Addressing Health Disparities of HPV Infection and Cervical cancer Development among Native American Women.
    Morales CG; Jimenez NR; Herbst-Kralovetz MM; Lee NR
    Med Sci (Basel); 2022 Sep; 10(3):. PubMed ID: 36135837
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Vaccination with human alphapapillomavirus-derived L2 multimer protects against human betapapillomavirus challenge, including in epidermodysplasia verruciformis model mice.
    Olczak P; Wong M; Tsai HL; Wang H; Kirnbauer R; Griffith AJ; Lambert PF; Roden R
    Virology; 2022 Oct; 575():63-73. PubMed ID: 36070626
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Human papillomavirus (HPV) integration signature in cervical lesions: identification of MACROD2 gene as HPV hot spot integration site.
    Zhao J; Zheng W; Wang L; Jiang H; Wang X; Hou J; Xu A; Cong J
    Arch Gynecol Obstet; 2023 Apr; 307(4):1115-1123. PubMed ID: 36008642
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Dissection of Capsid Protein HPV 52 to Rationalize Vaccine Designs Using Computational Approaches Immunoinformatics and Molecular Docking.
    Firdaus MER; Mustopa AZ; Triratna L; Syahputra G; Nurfatwa M
    Asian Pac J Cancer Prev; 2022 Jul; 23(7):2243-2253. PubMed ID: 35901328
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. New Perspectives in Therapeutic Vaccines for HPV: A Critical Review.
    Gardella B; Gritti A; Soleymaninejadian E; Pasquali MF; Riemma G; La Verde M; Schettino MT; Fortunato N; Torella M; Dominoni M
    Medicina (Kaunas); 2022 Jun; 58(7):. PubMed ID: 35888579
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Longitudinal follow-up of HPV16 sequence after cervical infection: Low intrahost variation and no correlation with clinical evolution.
    Debernardi A; Valot B; Almarcha J; Guenat D; Hocquet D; Algros MP; Riethmuller D; Ramanah R; Mougin C; Prétet JL; Lepiller Q
    J Med Virol; 2022 Nov; 94(11):5512-5518. PubMed ID: 35799409
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 11.